(IRM) Iron Mountain - Ratings and Ratios
Storage, Archiving, Data Centers, Asset Management
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 41.6% |
| Value at Risk 5%th | 67.8% |
| Relative Tail Risk | -1.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.88 |
| Alpha | -38.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.578 |
| Beta | 1.028 |
| Beta Downside | 1.239 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.03% |
| Mean DD | 9.40% |
| Median DD | 5.21% |
Description: IRM Iron Mountain October 14, 2025
Iron Mountain Incorporated (NYSE: IRM) provides information-management, digital-transformation, security, data-center, and asset-lifecycle services to over 240,000 customers in 61 countries, including roughly 95 % of the Fortune 1000. The company positions itself as a bridge between physical and digital assets, emphasizing safety, security, sustainability, and innovation.
Key operating metrics (FY 2023) show total revenue of $1.61 billion, an adjusted EBITDA margin of 38 %, and a portfolio occupancy rate of ~93 % across its storage and data-center facilities. IRM’s dividend yield sits near 5.2 % with a payout ratio of ≈ 70 %, reflecting its REIT-style cash-flow generation. The firm has delivered a compound annual revenue growth of ≈ 5 % over the past five years, driven largely by expanding data-center capacity.
Sector-wide, demand for secure off-site storage and colocation services is being accelerated by stricter data-privacy regulations (e.g., GDPR, CCPA) and the ongoing digital-transformation of enterprises, which raise the “information-as-an-asset” valuation. However, IRM’s valuation is sensitive to interest-rate movements, as higher rates compress REIT yields and increase borrowing costs for capital-intensive expansions.
For a deeper, data-driven assessment of IRM’s risk-adjusted upside, you may find the analytics on ValueRay worth exploring.
IRM Stock Overview
| Market Cap in USD | 27,008m |
| Sub-Industry | Other Specialized REITs |
| IPO / Inception | 1996-01-31 |
| Return 12m vs S&P 500 | -34.2% |
| Analyst Rating | 4.10 of 5 |
IRM Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 4.54% |
| Yield on Cost 5y | 18.93% |
| Yield CAGR 5y | 9.16% |
| Payout Consistency | 94.1% |
| Payout Ratio | 1.6% |
IRM Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 20.54% |
| CAGR/Max DD Calmar Ratio | 0.53 |
| CAGR/Mean DD Pain Ratio | 2.18 |
| Current Volume | 3687.9k |
| Average Volume | 1776.5k |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (159.3m TTM) > 0 and > 6% of Revenue (6% = 398.4m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -3.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -14.68% (prev -9.81%; Δ -4.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1.27b > Net Income 159.3m (YES >=105%, WARN >=100%) |
| Net Debt (18.28b) to EBITDA (2.08b) ratio: 8.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (298.0m) change vs 12m ago 1.49% (target <= -2.0% for YES) |
| Gross Margin 55.63% (prev 56.43%; Δ -0.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.96% (prev 32.42%; Δ 1.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.28 (EBITDA TTM 2.08b / Interest Expense TTM 822.2m) >= 6 (WARN >= 3) |
Altman Z'' -1.05
| (A) -0.05 = (Total Current Assets 1.88b - Total Current Liabilities 2.86b) / Total Assets 20.63b |
| (B) -0.25 = Retained Earnings (Balance) -5.24b / Total Assets 20.63b |
| (C) 0.05 = EBIT TTM 1.05b / Avg Total Assets 19.55b |
| (D) -0.26 = Book Value of Equity -5.61b / Total Liabilities 21.24b |
| Total Rating: -1.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.84
| 1. Piotroski 2.0pt |
| 2. FCF Yield -2.56% |
| 3. FCF Margin -17.44% |
| 4. Debt/Equity -20.95 |
| 5. Debt/Ebitda 8.81 |
| 6. ROIC - WACC (= -0.07)% |
| 7. RoE -22.34% |
| 8. Rev. Trend 99.25% |
| 9. EPS Trend 56.04% |
What is the price of IRM shares?
Over the past week, the price has changed by -9.16%, over one month by -21.57%, over three months by -8.34% and over the past year by -26.35%.
Is IRM a buy, sell or hold?
- Strong Buy: 4
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the IRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116.7 | 40.6% |
| Analysts Target Price | 116.7 | 40.6% |
| ValueRay Target Price | 105.5 | 27.1% |
IRM Fundamental Data Overview November 15, 2025
P/E Trailing = 169.2037
P/E Forward = 52.0833
P/S = 4.0676
P/B = 1516.5122
P/EG = 1.08
Beta = 1.132
Revenue TTM = 6.64b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 15.49b USD (from longTermDebt, last quarter)
Short Term Debt = 699.3m USD (from shortTermDebt, last quarter)
Debt = 18.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.28b USD (from netDebt column, last quarter)
Enterprise Value = 45.29b USD (27.01b + Debt 18.48b - CCE 195.2m)
Interest Coverage Ratio = 1.28 (Ebit TTM 1.05b / Interest Expense TTM 822.2m)
FCF Yield = -2.56% (FCF TTM -1.16b / Enterprise Value 45.29b)
FCF Margin = -17.44% (FCF TTM -1.16b / Revenue TTM 6.64b)
Net Margin = 2.40% (Net Income TTM 159.3m / Revenue TTM 6.64b)
Gross Margin = 55.63% ((Revenue TTM 6.64b - Cost of Revenue TTM 2.95b) / Revenue TTM)
Gross Margin QoQ = 54.85% (prev 55.91%)
Tobins Q-Ratio = 2.20 (Enterprise Value 45.29b / Total Assets 20.63b)
Interest Expense / Debt = 1.14% (Interest Expense 209.7m / Debt 18.48b)
Taxrate = 16.14% (16.6m / 102.8m)
NOPAT = 883.3m (EBIT 1.05b * (1 - 16.14%))
Current Ratio = 0.66 (Total Current Assets 1.88b / Total Current Liabilities 2.86b)
Debt / Equity = -20.95 (negative equity) (Debt 18.48b / totalStockholderEquity, last quarter -882.0m)
Debt / EBITDA = 8.81 (Net Debt 18.28b / EBITDA 2.08b)
Debt / FCF = -15.79 (negative FCF - burning cash) (Net Debt 18.28b / FCF TTM -1.16b)
Total Stockholder Equity = -712.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.77% (Net Income 159.3m / Total Assets 20.63b)
RoE = -22.34% (negative equity) (Net Income TTM 159.3m / Total Stockholder Equity -712.8m)
RoCE = 7.13% (EBIT 1.05b / Capital Employed (Equity -712.8m + L.T.Debt 15.49b))
RoIC = 6.14% (NOPAT 883.3m / Invested Capital 14.39b)
WACC = 6.21% (E(27.01b)/V(45.49b) * Re(9.80%) + D(18.48b)/V(45.49b) * Rd(1.14%) * (1-Tc(0.16)))
Discount Rate = 9.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.50%
Fair Price DCF = unknown (Cash Flow -1.16b)
EPS Correlation: 56.04 | EPS CAGR: 8.64% | SUE: 0.27 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 12.17% | SUE: 0.03 | # QB: 0
Additional Sources for IRM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle